About
Small Molecules
Areas of Focus
Categories
Small Molecule PharmaceuticalBoston & New England
Team (17)
Clinical Trials (5)
View allTotal Trials
5
As Lead Sponsor
0
As Collaborator
5
Total Enrollment
297
By Phase
PHASE2: 4NA: 1
By Status
RECRUITING: 2COMPLETED: 2ACTIVE_NOT_RECRUITING: 1
Clinical Trials Pipeline5 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2018
2019
2020
2021
2022
2023
2024
2025
2026
2027
Today
Hover over trial bars to see details
Recent Trials
NCT07033481Collaborator
Clinical Study of Neflamapimod in Patients With Primary Progressive Aphasia
PHASE2Recruiting
20 participants
Started: Aug 31, 2025 · Completed: Oct 31, 2026
NCT06987643Collaborator
A Clinical Study to Investigate the Effect of Oral Neflamapimod on Motor Recovery After Acute Ischaemic Stroke
PHASE2Recruiting
90 participants
Started: Jun 20, 2025 · Completed: Jun 28, 2026
NCT06815965Collaborator
A Clinical Study of Neflamapimod in Patients With Dementia With Lewy Bodies
PHASE2Active, not recruiting
25 participants
Started: Oct 16, 2024 · Completed: Apr 30, 2026
NCT05869669Collaborator
RewinD-LB - Clinical Study of Neflamapimod in Patients With Dementia With Lewy Bodies
PHASE2Completed
159 participants
Started: May 1, 2023 · Completed: Jun 16, 2025
NCT03995810Collaborator
Oral Carnosine for Neuromuscular Performance in Multiple Sclerosis
NACompleted
3 participants
Started: Jun 15, 2019 · Completed: Dec 1, 2019
Locations (1)
Headquarters
Boston, MA, United States
Map
Loading map...